| The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries AP Ambrosy, GC Fonarow, J Butler, O Chioncel, SJ Greene, ... Journal of the American College of Cardiology 63 (12), 1123-1133, 2014 | 2533 | 2014 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1536 | 2018 |
| Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry SJ Greene, J Butler, NM Albert, AD DeVore, PP Sharma, CI Duffy, CL Hill, ... Journal of the American College of Cardiology 72 (4), 351-366, 2018 | 1138 | 2018 |
| Mitochondrial function as a therapeutic target in heart failure DA Brown, JB Perry, ME Allen, HN Sabbah, BL Stauffer, SR Shaikh, ... Nature Reviews Cardiology 14 (4), 238-250, 2017 | 747 | 2017 |
| Titration of medical therapy for heart failure with reduced ejection fraction SJ Greene, GC Fonarow, AD DeVore, PP Sharma, M Vaduganathan, ... Journal of the American College of Cardiology 73 (19), 2365-2383, 2019 | 453 | 2019 |
| Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial M Gheorghiade, M Böhm, SJ Greene, GC Fonarow, EF Lewis, F Zannad, ... Jama 309 (11), 1125-1135, 2013 | 441 | 2013 |
| Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure A Dei Cas, SS Khan, J Butler, RJ Mentz, RO Bonow, A Avogaro, ... JACC: Heart Failure 3 (2), 136-145, 2015 | 434 | 2015 |
| The vulnerable phase after hospitalization for heart failure SJ Greene, GC Fonarow, M Vaduganathan, SS Khan, J Butler, ... Nature Reviews Cardiology 12 (4), 220-229, 2015 | 383 | 2015 |
| Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the … M Gheorghiade, SJ Greene, J Butler, G Filippatos, CSP Lam, ... Jama 314 (21), 2251-2262, 2015 | 376 | 2015 |
| Trends in 30-and 90-day readmission rates for heart failure MS Khan, J Sreenivasan, N Lateef, MS Abougergi, SJ Greene, T Ahmad, ... Circulation: Heart Failure 14 (4), e008335, 2021 | 233 | 2021 |
| Enrollment of older patients, women, and racial and ethnic minorities in contemporary heart failure clinical trials: a systematic review AS Tahhan, M Vaduganathan, SJ Greene, GC Fonarow, M Fiuzat, ... JAMA cardiology 3 (10), 1011-1019, 2018 | 200 | 2018 |
| Intravenous allogeneic mesenchymal stem cells for nonischemic cardiomyopathy: safety and efficacy results of a phase II-A randomized trial J Butler, SE Epstein, SJ Greene, AA Quyyumi, S Sikora, RJ Kim, ... Circulation Research 120 (2), 332-340, 2017 | 190 | 2017 |
| Simultaneous or rapid sequence initiation of quadruple medical therapy for heart failure—optimizing therapy with the need for speed SJ Greene, J Butler, GC Fonarow JAMA cardiology 6 (7), 743-744, 2021 | 188 | 2021 |
| Prevalence and prognostic impact of non‐cardiac co‐morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community‐based study A Iorio, M Senni, G Barbati, SJ Greene, S Poli, E Zambon, C Di Nora, ... European journal of heart failure 20 (9), 1257-1266, 2018 | 188 | 2018 |
| Soluble guanylate cyclase: a potential therapeutic target for heart failure M Gheorghiade, CN Marti, HN Sabbah, L Roessig, SJ Greene, M Böhm, ... Heart failure reviews 18, 123-134, 2013 | 176 | 2013 |
| The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction SJ Greene, M Gheorghiade, BA Borlaug, B Pieske, M Vaduganathan, ... Journal of the American Heart Association 2 (6), e000536, 2013 | 164 | 2013 |
| Initiation, continuation, switching, and withdrawal of heart failure medical therapies during hospitalization AA Bhagat, SJ Greene, M Vaduganathan, GC Fonarow, J Butler JACC: Heart Failure 7 (1), 1-12, 2019 | 163 | 2019 |
| Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial M Vaduganathan, AP Ambrosy, SJ Greene, RJ Mentz, HP Subacius, ... Circulation: Heart Failure 5 (6), 750-758, 2012 | 158 | 2012 |
| Kidney function and outcomes in patients hospitalized with heart failure RB Patel, GC Fonarow, SJ Greene, S Zhang, B Alhanti, AD DeVore, ... Journal of the American College of Cardiology 78 (4), 330-343, 2021 | 154 | 2021 |
| Haemoconcentration, renal function, and post‐discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial SJ Greene, M Gheorghiade, M Vaduganathan, AP Ambrosy, RJ Mentz, ... European journal of heart failure 15 (12), 1401-1411, 2013 | 151 | 2013 |
